Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Outdoor Guide
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
Readersâ Choice
Auction
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AN2 Therapeutics, Inc. - Common Stock
(NQ:
ANTX
)
6.410
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
6.410
Bid (Size)
5.250 (1)
Ask (Size)
6.710 (1)
Prev. Close
6.410
Today's Range
6.410 - 6.410
52wk Range
4.870 - 22.49
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AN2 Therapeutics to Present at Jefferies Healthcare Conference
May 25, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 16, 2023
Via
Benzinga
Performance
YTD
-34.05%
-34.05%
1 Month
+12.46%
+12.46%
3 Month
-33.02%
-33.02%
6 Month
-29.17%
-29.17%
1 Year
-51.44%
-51.44%
More News
Read More
AN2 Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights
May 11, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
AN2 Therapeutics to Present at JMP Securities Life Sciences Conference
May 01, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
AN2 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
March 29, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
AN2 Therapeutics to Participate in Upcoming Investor Conferences
February 28, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
AN2 Therapeutics to Present at SVB Securities Global Biopharma Conference
January 31, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
Top 5 Health Care Stocks That May Dip
January 27, 2023
Via
Benzinga
Lennar To Rally Around 14%? Plus Keybanc Predicts $5,120 For This Stock
November 14, 2022
Via
Benzinga
AN2 Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 09, 2022
From
AN2 Therapeutics, Inc.
Via
GlobeNewswire
AN2 Therapeutics to Present at Upcoming Investor Conferences
November 02, 2022
From
AN2 Therapeutics, Inc.
Via
GlobeNewswire
AN2 Therapeutics to Present New Epetraborole Data at IDWeek 2022
October 19, 2022
From
AN2 Therapeutics, Inc.
Via
GlobeNewswire
Uber, Lyft, AZZ And Other Big Losers From Tuesday
October 12, 2022
Via
Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
October 12, 2022
Via
Benzinga
AN2 Therapeutics Provides Update on Epetraborole Ex-U.S. Development Plan in Treatment-Refractory MAC Lung Disease
October 06, 2022
From
AN2 Therapeutics, Inc.
Via
GlobeNewswire
NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8 Million
September 29, 2022
From
AN2 Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 27, 2022
Via
Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 12, 2022
Via
Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
September 23, 2022
Via
Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
September 07, 2022
Via
Benzinga
Nasdaq Drops 200 Points; American Woodmark Shares Spike Higher
August 30, 2022
Via
Benzinga
How Is The Market Feeling About AN2 Therapeutics?
August 15, 2022
Via
Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
August 12, 2022
Via
Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
August 15, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.